Iovance Biotherapeutics Announces Updates to Tumor Infiltrating Lymphocyte (TIL) Therapy Clinical Programs

Paul Theisen
Patient Acquisition

Stacey Gandler
Brand Nourishment

Bud Bilanich
Success Coach

David Linetsky
Point-of-Care Marketing

Matthew Durham
Omnidynamic Marketing

Matt Turner
Patient Affordability

Joey Cohen
Medication Adherence

Frank Burrell
Scientific Storytelling

Daniel Sontupe
Market Access

Suma Ramadas, PhD
Medical Affairs

Pat Purcell
Meeting Engagement

Liz Kane
Impactful Strategy

Brenda Snow
Authentic Patient Voice

Amy Giles
Increasing Engagement